Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-8091017
  • Global Vascular Stents Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: October 2017 | Report Code: HME-8091017

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Vascular stents such as coronary stents, peripheral stents etc. offer insertion of a metal or plastic tube within the anatomic vessel during angioplasty surgeries for the treatment of vascular diseases such as, atherosclerosis and peripheral artery disease, aneurysm, buerger’s diseases etc. The global vascular stent market is expected to rise at a CAGR of about 7.5% during the forecast period 2016-2023.According to the University of Minnesota Health, United States, vascular stents is majorly used by interventional cardiologists for treatment of coronary artery disease. Moreover, according to the Mayo Clinic, United States, drug eluting stents are the most preferred type as theses are more likely to keep any of the blockages from recurring. It also eliminates the need for repeat angioplasty procedures.

Rising prevalence of vascular diseases among geriatric population is one of the major factors which contribute to the growth of global vascular stent market during the forecast period. According to the National Center for Biotechnology Information (NCBI), United States, vascular diseases are highly prevalent among geriatric population due to factors such as pulmonary vasculature and pulmonary hypertension with age associated stiffening of the heart. According to the National institute of health (NIH), United States, global geriatric population is expected to reach to about 1.6 billion by the end of 2050 from 617 million in 2015. As per NCBI, Korean geriatric population is expected to reach 24.3% (aged 65 or older) by the end of 2030. This is expected to increase the risk factors associated with cardio vascular diseases which increases the demand for vascular stents and is expected to promote the market growth during the forecast period.

Source: OBRC Analysis

The report on the global vascular stent market is segmented on the basis of type, product, mode of delivery, material and end users.

Types of vascular stent include:

  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioabsorbable Stent




Products in vascular stent are divided as:

  • Coronary Stents
  • Peripheral Stents



o   Carotid Artery Stents

o   Renal Artery Stents

o   Femoral Artery Stents

o   Other Stents

  • Evar Stent Grafts


o   Abdominal Aortic Aneurysm Stents

o   Thoracic Aortic Aneurysm Stents

Mode of delivery in vascular stent includes:

  • Balloon-Expandable Stents
  • Self-Expanding Stents



Materials in vascular stent are divided as:

  • Metallic Stents


o   Cobalt Chromium

o   Platinum Chromium

o   Nickel Titanium

o   Stainless Steel

  • Other Stents


End users adopting vascular stent include:

  • Hospitals and Cardiac Centers
  • Ambulatory Surgical Centers



The report scope is widely categorized on the basis of its segments such as type, product, mode of delivery, material and end users. Moreover, the market revenue estimates and forecast includes only vascular stent. However, the report scope excludes other treatment methods such as drug treatment, etc.

Geographically, the global vascular stent market report has been segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America accounted for the largest market share in terms of revenue for the vascular stent market in 2016 followed by Europe and is expected to dominate the market during forecast period. Dominance of North America, during the forecast period is witnessed due to rising prevalence of cardio vascular diseases across regions such as United States, etc. According to the American Heart Association, United States, about 41.5% of the total U.S. population had cardiovascular diseases. This is expected to reach up to 45% cardiovascular diseases cases in United States by the end of 2035. Moreover, according to the Centers for Disease Control and Prevention (CDCP), United States, nearly 630,000 Americans die from heart disease each year (1 in every 4 deaths). Such factors contribute to the dominance of North America vascular stent market during forecast period. Furthermore, Asia Pacific is expected to be the fastest growing region for stent market during the forecast period due to growing geriatric population in the region. Countries such as China and India majorly contribute towards the fastest growth rate of Asia Pacific vascular stent market during the forecast period.

Global vascular stent market report covers segmentation analysis of type, product, mode of delivery, material and end users. Report further covers segments of type which include drug-eluting stents, bare-metal stents and bioabsorbable stent. According to OBRC analysis, drug-eluting stent held the largest market share in terms of revenue in 2016 and is expected to dominate the type segment during the forecast period. The dominance is witnessed due to numerous advantages of drug-eluting stents over bare-metal stent such as s lower risk of restenosis, etc. Furthermore, Mode of delivery in vascular stent includes balloon expandable stents and self expanding stents. Balloon expandable stents segment is expected to grow at the highest rate during the forecast period, as per OBRC analysis. Fastest growth rate of balloon expandable stents is expected due to increasing regulatory approvals for balloon-expandable stents and its high usage in angioplasty procedures.

The major market players of the global vascular stent market are:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic Plc
  • Microport Scientific Corporation
  • TransluminaGmbh
  • Others







These companies use various strategies such as merger & acquisition, collaboration, partnership, product launch, etc.whereas, product launch is the key strategy adopted by the companies in the global vascular stent market.

For example: In 2017, Medtronic Plc. launched resolute Onyx drug-eluting stent. It uses core wire technology in which radiopaque inner core is incorporated within cobalt alloy wire. It enhances the visibility for accurate stent placement. This is used in the treatment of vascular diseases.

In 2016, Abbott Laboratories announced launch of GT1 Bioresorbable Vascular Scaffold System (BVS). It is the first absorbable stent for the treatment of coronary artery disease, approved bt the U.S. Food and Drug Administration (FDA). Its development is expected to promote the market growth.

Key reasons to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023.
  • Report includes detailed analysis of different segments such as type, product, mode of delivery, material and end users.
  • Identify and understand the strength, challenges, opportunities and threat of the market during the forecast period.
  • Covers detailed analysis of Porters 5 force model and other strategic models. Also covers revenues, market share analysis, and competitive landscape analysis of major players.
  • Detailed analysis of various regulatory policies which are affecting the global vascular stentmarket during the forecast period.






How are we different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on the global vascular stentmarket offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the global vascular stent market, with giving extensive SCOT analysis of key companies.

Key findings of the global vascular stent market:

  • Rising prevalence of vascular diseases among geriatric population promotes the market growth during forecast period.
  • North America is expected to dominate vascular stent market during the forecast period.
  • Balloon expandable stents segment is expected to be the fastest growing segment during the forecast period.
  • Product launch is the key strategy adopted by the companies in the global vascular stent market during the forecast period. 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL VASCULAR STENT MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RAPID GROWTH IN THE GERIATRIC POPULATION
3.1.2. INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. RISING INCIDENCE OF VASCULAR DISEASES
3.1.4. INNOVATIONS IN STENTING TECHNOLOGIES
3.2. MARKET RESTRAINTS
3.2.1. PRODUCT FAILURES AND RECALLS
3.2.2. AVAILABILITY OF ALTERNATIVE TREATMENT METHODS FOR VASCULAR DISEASES
3.3. MARKET OPPORTUNITIES
3.3.1. DEVELOPMENT OF BIORESORBABLE STENTS
3.3.2. INCREASING DEMAND FROM EMERGING MARKETS
3.4.   MARKET CHALLENGES 
3.4.1. COMPLICATIONS ASSOCIATED WITH STENT IMPLANTATION
3.4.2. LACK OF AWARENESS AMONG GENERAL POPULATION
 
4. MARKET SEGMENTATION 
4.1. GLOBAL VASCULAR STENT MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBALDRUG-ELUTING STENTS MARKET 
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL BARE-METAL STENTSMARKET 
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL BIOABSORBABLE STENTS MARKET 
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY  PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL VASCULAR STENT MARKET BY PRODUCT
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL CORONARY STENTSMARKET 
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBALPERIPHERAL STENTSMARKET 
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.2.5. MARKET SUB-SEGMENTS
4.2.5.2.5.1. CAROTIDARTERY STENTS
4.2.5.2.5.2. RENAL ARTERY STENTS
4.2.5.2.5.3. FEMORAL ARTERY STENTS
4.2.5.2.5.4. OTHER STENTS
4.2.5.3. GLOBALEVAR STENT GRAFTSMARKET 
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.2.5.3.4. KEY CONCLUSIONS
4.2.5.3.5. MARKET SUB-SEGMENTS
4.2.5.3.5.1. ABDOMINAL AORTIC ANEURYSM STENTS
4.2.5.3.5.2. THORACIC AORTIC ANEURYSM STENTS
4.3. GLOBAL VASCULAR STENT MARKET BY MODE OF DELIVERY
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL BALLOON-EXPANDABLE STENTSMARKET 
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBALSELF-EXPANDING STENTSMARKET 
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
4.4. GLOBAL VASCULAR STENT MARKET BY MATERIAL
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL METALLIC STENTSMARKET 
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.1.5. MERKET SUB-SEGMENTS
4.4.5.1.5.1. COBALT CHROMIUM
4.4.5.1.5.2. PLATINUM CHROMIUM
4.4.5.1.5.3. NICKEL TITANIUM
4.4.5.1.5.4. STAINLESS STEEL
4.4.5.2. GLOBALOTHER STENTSMARKET 
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.5. GLOBAL VASCULAR STENT MARKET BY END USER
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION 
4.5.5.1. GLOBAL HOSPITALS AND CARDIAC CENTERSMARKET 
4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.1.4. KEY CONCLUSIONS
4.5.5.2. GLOBALAMBULATORY SURGICAL CENTERSMARKET 
4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.5.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.2.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL VASCULAR STENTMARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY  PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY  PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY  PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ABBOTT LABORATORIES (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. B. BRAUN MELSUNGEN AG (GERMANY)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. BIOTRONIK SE & CO. KG (GERMANY)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS 
7.3.5. STRATEGIC ANALYSIS
7.4. BOSTON SCIENTIFIC CORPORATION (U.S)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. C.R. BARD, INC. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. CORDIS CORPORATION (U.S.)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. ENDOLOGIX, INC. (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.7.6.
7.8. LOMBARD MEDICAL (U.K.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. MEDTRONIC PLC (U.S.)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. MERIL LIFE SCIENCES PVT. LTD. (INDIA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. MICROPORT SCIENTIFIC CORPORATION (CHINA)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. TERUMO CORPORATION (JAPAN)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS 
7.12.5. STRATEGIC ANALYSIS
7.13. TRANSLUMINA GMBH (GERMANY)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. VASCULAR CONCEPTS LIMITED (INDIA)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. W.L. GORE AND ASSOCIATES, INC. (U.S.)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL VASCULAR STENT MARKET BY TYPE2014-2023 ($ MILLION)
2. GLOBAL DRUG-ELUTING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL BARE-METAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL BIOABSORBABLE STENTS MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL VASCULAR STENT MARKET BY PRODUCT 2014-2023 ($ MILLION)
6. GLOBALCORONARY STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL PERIPHERAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL VASCULAR STENT MARKET BYPERIPHERAL STENTS2014-2023 ($ MILLION)
9. GLOBAL EVAR STENT GRAFTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL VASCULAR STENT MARKET BYEVAR STENT GRAFTS2014-2023 ($ MILLION)
11. GLOBAL VASCULAR STENT MARKET BY MODE OF DELIVERY2014-2023 ($ MILLION)
12. GLOBAL BALLOON-EXPANDABLE STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL SELF-EXPANDING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL VASCULAR STENT MARKET BYMATERIAL2014-2023 ($ MILLION)
15. GLOBAL METALLIC STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL VASCULAR STENT MARKET BYMETALLIC STENTS2014-2023 ($ MILLION)
17. GLOBAL OTHER STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. GLOBAL VASCULAR STENT MARKET BY END USER 2014-2023 ($ MILLION)
19. GLOBAL HOSPITALS AND CARDIAC CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL AMBULATORY SURGICAL CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. NORTH AMERICA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
22. EUROPE VASCULAR STENT  MARKET 2014-2023 ($ MILLION)
23. ASIA PACIFIC VASCULAR STENT MARKET 2014-2023 ($ MILLION)
24. REST OF THE WORLD VASCULAR STENT MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL VASCULAR STENT MARKET BY TYPE2014-2023 ($ MILLION)
2. GLOBAL DRUG-ELUTING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL BARE-METAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL BIOABSORBABLE STENTS MARKET  BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL VASCULAR STENT MARKET BY PRODUCT 2014-2023 ($ MILLION)
6. GLOBALCORONARY STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL PERIPHERAL STENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL CAROTID ARTERY STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL RENAL ARTERY STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL FEMORAL ARTERY STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL OTHER STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL EVAR STENT GRAFTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL ABDOMINAL AORTIC ANEURYSM STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL THORACIC AORTIC ANEURYSM STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL VASCULAR STENT MARKET BY MODE OF DELIVERY2014-2023 ($ MILLION)
16. GLOBAL BALLOON-EXPANDABLE STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL SELF-EXPANDING STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. GLOBAL VASCULAR STENT MARKET BYMATERIAL2014-2023 ($ MILLION)
19. GLOBAL METALLIC STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL COBALT CHROMIUMMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. GLOBAL PLATINUM CHROMIUMMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
22. GLOBAL NICKEL TITANIUMMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
23. GLOBAL STAINLESS STEELMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
24. GLOBAL OTHER STENTSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
25. GLOBAL VASCULAR STENT MARKET BY END USER 2014-2023 ($ MILLION)
26. GLOBAL HOSPITALS AND CARDIAC CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL AMBULATORY SURGICAL CENTERSMARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. UNITED STATES (U.S.) VASCULAR STENT  MARKET 2014-2023 ($ MILLION)
22. CANADA VASCULAR STENT  MARKET 2014-2023 ($ MILLION)
23. UNITED KINGDOM (UK) VASCULAR STENT MARKET 2014-2023 ($ MILLION)
24. FRANCE VASCULAR STENT  MARKET 2014-2023 ($ MILLION)
25. GERMANY VASCULAR STENT MARKET 2014-2023 ($ MILLION)
26. SPAIN VASCULAR STENT MARKET 2014-2023 ($ MILLION)
27. ROE VASCULAR STENT MARKET 2014-2023 ($ MILLION)
28. INDIA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
29. CHINA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
30. JAPAN VASCULAR STENT MARKET 2014-2023 ($ MILLION)
31. AUSTRALIA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
32. ROAPAC VASCULAR STENT MARKET 2014-2023 ($ MILLION)
33. LATIN AMERICA VASCULAR STENT MARKET 2014-2023 ($ MILLION)
34. MENA VASCULAR STENT MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion